Skip to content
2000
Volume 31, Issue 8
  • ISSN: 0929-8673
  • E-ISSN: 1875-533X

Abstract

This patent describes the series of compounds and their pharmaceutically acceptable salts, such as compound K7 (as a representative potent compound). These protein kinase C selective inhibitors are useful for treating diabetes mellitus and its complications, cancer, ischemia, inflammation, central nervous system disorders, cardiovascular disease, Alzheimer's disease, dermatological disease, virus diseases, inflammatory disorders, or diseases in which the liver is a target organ.

Loading

Article metrics loading...

/content/journals/cmc/10.2174/0929867330666230531164754
2024-03-01
2025-07-08
Loading full text...

Full text loading...

/content/journals/cmc/10.2174/0929867330666230531164754
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test